{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:04:46Z","timestamp":1784016286824,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nano.2026.102962","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:01:27Z","timestamp":1779897687000},"page":"102962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Macrophage membrane-biomimetic nanoparticles for targeted delivery of melatonin in myocardial ischemia-reperfusion injury"],"prefix":"10.1016","volume":"75","author":[{"given":"Tian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guogang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nano.2026.102962_bb0005","first-page":"1385","article-title":"An end-to-end reactive oxygen species scavenger for targeted therapy of myocardial ischemia-reperfusion injury by concurrently eliminating superoxide anion and hydroxyl radical","volume":"532","author":"Shuya","year":"2026","journal-title":"Chem Eng J"},{"key":"10.1016\/j.nano.2026.102962_bb0010","first-page":"47","article-title":"Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries","volume":"7","author":"Zhao","year":"2022","journal-title":"Bioact Mater"},{"issue":"14","key":"10.1016\/j.nano.2026.102962_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404979","article-title":"Targeted anti-inflammatory nanozymes with pro-angiogenic activity for myocardial infarction therapy","volume":"14","author":"Yang","year":"2025","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"10.1016\/j.nano.2026.102962_bb0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0008-6363(02)00827-1","article-title":"Melatonin: a novel protective agent against oxidative injury of the ischemic\/reperfused heart","volume":"58","author":"Reiter","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.nano.2026.102962_bb0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/jcph.592","article-title":"Pharmacokinetics of high-dose intravenous melatonin in humans","volume":"56","author":"Andersen","year":"2015","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.nano.2026.102962_bb0030","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/cns.13261","article-title":"Melatonin protects against ischemic stroke by modulating microglia\/macrophage polarization toward anti-inflammatory phenotype through STAT3 pathway","volume":"25","author":"Liu","year":"2019","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"10.1016\/j.nano.2026.102962_bb0035","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1159\/000491474","article-title":"Melatonin attenuates myocardial ischemia\/reperfusion injury by inhibiting autophagy via an AMPK\/mTOR signaling pathway","volume":"47","author":"Chen","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"10.1016\/j.nano.2026.102962_bb0040","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/s41557-024-01584-z","article-title":"Engineering a nanoscale liposome-in-liposome for in situ biochemical synthesis and multi-stage release","volume":"16","author":"Pilkington","year":"2024","journal-title":"Nat Chem"},{"issue":"6","key":"10.1016\/j.nano.2026.102962_bb0045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41565-024-01620-6","article-title":"Chimeric nanobody-decorated liposomes by self-assembly","volume":"19","author":"Rahman","year":"2024","journal-title":"Nat Nanotechnol"},{"issue":"25","key":"10.1016\/j.nano.2026.102962_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202309031","article-title":"Construction strategy of functionalized liposomes and multidimensional application","volume":"20","author":"Wang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.nano.2026.102962_bb0055","doi-asserted-by":"crossref","unstructured":"Neethling, William M.L. et al., Interstitial pH during myocardial preservation: assessment of five methods of myocardial preservation. Ann Thorac Surg, 55, 2, 420\u2013426.","DOI":"10.1016\/0003-4975(93)91014-E"},{"issue":"1","key":"10.1016\/j.nano.2026.102962_bb0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12951-021-00926-0","article-title":"Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19","volume":"19","author":"Tan","year":"2021","journal-title":"J Nanobiotechnol"},{"issue":"26","key":"10.1016\/j.nano.2026.102962_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202402445","article-title":"Revolutionizing neurocare: biomimetic nanodelivery via cell membranes","volume":"36","author":"Liao","year":"2024","journal-title":"Adv Mater"},{"issue":"1","key":"10.1016\/j.nano.2026.102962_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","article-title":"Targeting strategies for tissue-specific drug delivery","volume":"181","author":"Zhao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.nano.2026.102962_bb0080","article-title":"Engineered macrophage membrane-coated S100A9-siRNA for ameliorating myocardial ischemia-reperfusion injury","author":"Lu","year":"2024","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.nano.2026.102962_bb0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget strategies to reduce myocardial ischemia\/reperfusion injury","volume":"73","author":"Davidson","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:24:55Z","timestamp":1784013895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":16,"alternative-id":["S1549963426000638"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102962","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage membrane-biomimetic nanoparticles for targeted delivery of melatonin in myocardial ischemia-reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102962"}}